Compare FMNB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMNB | ZVRA |
|---|---|---|
| Founded | 1887 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.3M | 499.9M |
| IPO Year | N/A | 2015 |
| Metric | FMNB | ZVRA |
|---|---|---|
| Price | $14.03 | $8.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $14.50 | ★ $21.71 |
| AVG Volume (30 Days) | 174.8K | ★ 1.4M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.86% | N/A |
| EPS Growth | ★ 17.06 | N/A |
| EPS | ★ 1.44 | 0.54 |
| Revenue | ★ $178,552,000.00 | $84,388,000.00 |
| Revenue This Year | $22.69 | $336.43 |
| Revenue Next Year | $41.03 | $54.26 |
| P/E Ratio | ★ $9.72 | $16.12 |
| Revenue Growth | 9.57 | ★ 244.60 |
| 52 Week Low | $11.58 | $6.19 |
| 52 Week High | $16.07 | $13.16 |
| Indicator | FMNB | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 64.20 | 43.13 |
| Support Level | $13.51 | $8.12 |
| Resistance Level | $13.73 | $8.75 |
| Average True Range (ATR) | 0.30 | 0.51 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 94.05 | 33.21 |
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.